- Home
- ARVN vs MAG Comparison
ARVN vs MAG Comparison
Compare ARVN & MAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- MAG
- Stock Information
- Founded
- ARVN 2015
- MAG 1999
- Country
- ARVN United States
- MAG Canada
- Employees
- ARVN N/A
- MAG N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- MAG Precious Metals
- Sector
- ARVN Health Care
- MAG Basic Materials
- Exchange
- ARVN Nasdaq
- MAG Nasdaq
- Market Cap
- ARVN 1.7B
- MAG 1.6B
- IPO Year
- ARVN 2018
- MAG N/A
- Fundamental
- Price
- ARVN $25.76
- MAG $17.52
- Analyst Decision
- ARVN Strong Buy
- MAG Strong Buy
- Analyst Count
- ARVN 15
- MAG 3
- Target Price
- ARVN $57.50
- MAG $18.00
- AVG Volume (30 Days)
- ARVN 487.9K
- MAG 685.0K
- Earning Date
- ARVN 10-30-2024
- MAG 11-08-2024
- Dividend Yield
- ARVN N/A
- MAG N/A
- EPS Growth
- ARVN N/A
- MAG 88.67
- EPS
- ARVN N/A
- MAG 0.59
- Revenue
- ARVN $93,300,000.00
- MAG N/A
- Revenue This Year
- ARVN $179.49
- MAG N/A
- Revenue Next Year
- ARVN N/A
- MAG $241.53
- P/E Ratio
- ARVN N/A
- MAG $29.62
- Revenue Growth
- ARVN N/A
- MAG N/A
- 52 Week Low
- ARVN $13.57
- MAG $8.20
- 52 Week High
- ARVN $53.08
- MAG $17.62
- Technical
- Relative Strength Index (RSI)
- ARVN 50.68
- MAG 77.81
- Support Level
- ARVN $25.42
- MAG $15.54
- Resistance Level
- ARVN $29.24
- MAG $16.18
- Average True Range (ATR)
- ARVN 1.24
- MAG 0.58
- MACD
- ARVN 0.18
- MAG 0.17
- Stochastic Oscillator
- ARVN 34.71
- MAG 97.16
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which achieved commercial production of around 4,000 tonnes per day. The company has also Interest in the Larder project. Also, MAG has an expanded exploration program targeting multiple prospective targets at both Juanicipio and the Deer Trail 100% earn-in project in Utah. The Juanicipio Mine recognizes revenue for silver, gold, lead, and zinc from concentrate sales.